Panzarini, E.; Leporatti, S.; Tenuzzo, B.A.; Quarta, A.; Hanafy, N.A.N.; Giannelli, G.; Moliterni, C.; Vardanyan, D.; Sbarigia, C.; Fidaleo, M.;
et al. Therapeutic Effect of Polymeric Nanomicelles Formulation of LY2157299-Galunisertib on CCl4-Induced Liver Fibrosis in Rats. J. Pers. Med. 2022, 12, 1812.
https://doi.org/10.3390/jpm12111812
AMA Style
Panzarini E, Leporatti S, Tenuzzo BA, Quarta A, Hanafy NAN, Giannelli G, Moliterni C, Vardanyan D, Sbarigia C, Fidaleo M,
et al. Therapeutic Effect of Polymeric Nanomicelles Formulation of LY2157299-Galunisertib on CCl4-Induced Liver Fibrosis in Rats. Journal of Personalized Medicine. 2022; 12(11):1812.
https://doi.org/10.3390/jpm12111812
Chicago/Turabian Style
Panzarini, Elisa, Stefano Leporatti, Bernardetta Anna Tenuzzo, Alessandra Quarta, Nemany A. N. Hanafy, Gianluigi Giannelli, Camilla Moliterni, Diana Vardanyan, Carolina Sbarigia, Marco Fidaleo,
and et al. 2022. "Therapeutic Effect of Polymeric Nanomicelles Formulation of LY2157299-Galunisertib on CCl4-Induced Liver Fibrosis in Rats" Journal of Personalized Medicine 12, no. 11: 1812.
https://doi.org/10.3390/jpm12111812
APA Style
Panzarini, E., Leporatti, S., Tenuzzo, B. A., Quarta, A., Hanafy, N. A. N., Giannelli, G., Moliterni, C., Vardanyan, D., Sbarigia, C., Fidaleo, M., Tacconi, S., & Dini, L.
(2022). Therapeutic Effect of Polymeric Nanomicelles Formulation of LY2157299-Galunisertib on CCl4-Induced Liver Fibrosis in Rats. Journal of Personalized Medicine, 12(11), 1812.
https://doi.org/10.3390/jpm12111812